Sanitas Growing Strongly In CEE

Lithuanian pharmaceutical group Sanitas has posted impressive Q108 results, with year-on-year (y-o-y) revenues up by 26% from LTL77.0mn (US$35.3) to LTL96.7mn (US$44.3mn). The group also improved its profit margins, which contributed to a 66% increase in y-o-y net profits to LTL10.3

To read the full article, please take a trial.